Skip to main content

Select Drug Profiles

Conference Highlights NCCN
NCCN Panel Debates the Economics of Cancer Care
Caroline Helwick
Read More
Conference Highlights NCCN
PET Scans Not Recommended for Most Patients with Breast Cancer: Potential New Controversy in Breast Cancer Testing
Caroline Helwick
Read More
Practice Management
Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point?
Rebecca Hyde, Diana Dobrovolny
Stakeholder Perspective
Orphan Drugs: The Potential Impact of Generic Biologics
by Kavita V. Nair, PhD
Read More
Practice Management
Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care
Alyssa Pozniak, PhD, Lois Olinger, MA, Victoria Shier, MA
Stakeholder Perspective
Diabetes Management Strategies: More Money Does Not Equal Better Care
by Gary M. Owens, MD
Read More
Original Research
Hypertension Management: An Update
Joann Dominguez, MD, Loida Nguyen, PharmD, Nageshwara Gullapalli, MD, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Hypertension Management: Implications to Patients, Providers, and Payers
by Lekshmi Dharmarajan, MD, FACP, FACC
Read More
Practice Management
Competition from Biosimilars an Incentive for Innovation
Dalia Buffery, MA, ABD
Read More
Practice Management
Emerging Trends in Breast Cancer Management
Caroline Helwick
Read More
Practice Management
Rheumatology Pipeline Boasts Innovation, ID Line Is Drying Up: ACR/IDSA 2009
Alice Goodman
Read More
Practice Management
Cardiology Pipeline Is Promising: AHA 2009
Wayne Kuznar
Read More
Perspectives
Wellness and the Governing Dynamics of Healthcare Reform
Robert E. Henry
Read More
Page 241 of 244
Results 2401 - 2410 of 2438